Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹4,509.20
63.70 (1.39%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹20.63K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
29.0
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹4,396.7+2.6%
52W High₹5,993-24.8%
Current Price
₹4,509.20
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹3,607.36
Upper Circuit₹5,411.04
Reference Price
₹4,509.20
Investment Checklist
Double Top on 1W (BREAKOUT CONFIRMED) — target ₹4355.0
Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹4695.7
Trend: Price below most MAs — downtrend | Bearish MA stack (20<50<200)
Composite score -50.1 (SELL) with 55.0% confidence
Volume divergence: Bullish (price down, volume up)
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
55%
Trend
BEARISH
BEARISH
Price below most MAs — downtrend | Bearish MA stack (20<50<200)
EMA20
4590.66
EMA50
4680.6
EMA200
4944.61
Price Action
MIXED
NEUTRAL
Higher Highs2
Higher Lows4
Lower Highs7
Lower Lows5
Support & Resistance Levels
Resistance (Above)
₹4521.50
₹4624.37
₹4747.75
₹4925.64
₹5105.79
Support (Below)
₹4460.00
₹4396.70
Volume Analysis
TrendINCREASING
Change+34.20%
Unusual VolumeNo
Divergence Detected
Bullish (price down, volume up)
Stop Loss Levels
Fixed Risk
1% Risk₹4464.11
3% Risk₹4373.92
5% Risk₹4283.74
7% Risk (Custom)
₹4193.56Technical Levels
1x ATR (Volatility)₹4386.75
2x ATR (Swing)₹4264.30
3x ATR (Trend)₹4141.85
Immediate Support₹4460.00
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹591.6 Cr | ₹603.1 Cr | ₹642.3 Cr | ₹645 Cr |
| Net Profit | ₹330.9 Cr | ₹191.8 Cr | ₹189 Cr | ₹141.8 Cr |
| EPS | — | ₹41.91 | ₹41.32 | ₹31.01 |
| Operating Profit | ₹444.9 Cr | ₹277.2 Cr | ₹271.8 Cr | ₹208.2 Cr |
ROE
18.20%
ROCE
23.68%
Debt/Equity
0.03
Current Ratio
6.17
OPM
32.28%
NPM
21.99%
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 09 Jul 2025 | Dividend - Rs 35 Per Share & Special Dividend Of Rs 100 Per Share/ Special Dividend Of Rs 30 | SPECIAL_DIVIDEND |
| 21 Aug 2024 | Dividend - Rs 35 Per Share | DIVIDEND |
| 11 Aug 2023 | Dividend - Rs 35 Per Share/ Special Dividend - Rs 5 Per Share | SPECIAL_DIVIDEND |
| 19 Sept 2022 | Special Dividend - Rs 30 Per Share | SPECIAL_DIVIDEND |
| 18 Aug 2022 | Dividend - Rs 35 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for PFIZER
View All
positive
CNBC TV18 - Markets 5d ago
Here is the one sector bucking the trend in a weak market; Check out top gainers
Five among the top 10 gainers on the Nifty 500 index are Pharma stocks. They include Pfizer (Up 4.6%), Anthem Biosciences (Up 2.5%), Syngene (Up 2%), Aster DM Healthcare (Up 2%) and Wockhardt (Up 2%).
ANTHEMAONELIQUIDAONENIFTYAONETMMQ50AONETOTALASTERDMAXISHCETFBANKIETFESGGROWWLOVOLGROWWMOM50HCGHCG-REHEALTHADDHEALTHCAREHEALTHIETFHEALTHYMASPTOP50MOCAPITALMOMENTUM50MONIFTY500MOSERVICEMULTICAPPFIZERPHARMABEESPVTBANIETFSDL26BEESSYNGENETOP10ADDTOP15IETFTOP20VALUEWOCKPHARMAFinancial ServicesFINANCIAL SERVICES
neutral
ET Markets - Industry 30d ago
From oncology to obesity, Pfizer bets big on India for its next growth wave
Pfizer is focusing on India for future growth. The company plans to launch new medicines quickly and at affordable prices. India is seen as a crucial market for new treatments in cancer, obesity, and vaccines. Pfizer is also working on local clinical studies for future drug launches.
AFFORDABLEFELFELDVRFMNLPFIZERCapital GoodsConsumer Services
NEWS
positive
Business Standard - Markets 31d ago
Pfizer standalone net profit declines 39.62% in the March 2026 quarter
Sales rise 6.31% to Rs 629.23 crore
PFIZERHealthcare